Compass Financial Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Buy
53
+1
+2% +$108 ﹤0.01% 1121
2026
Q2
$3.64K Buy
+52
New +$2.69K ﹤0.01% 1245

Other funds holding MRNA

Compass Financial Management's MRNA Position: Q3 2026 in Review

Compass Financial Management increased its Moderna (MRNA) stake by 1.9% in Q3 2026, buying an estimated $108 and bringing the position to 53 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Compass Financial Management first reported a position in MRNA in Q2 2026 and has held it in 2 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Compass Financial Management held 53 shares of Moderna worth $10.2K as of Q3 2026.
  • Compass Financial Management bought 1 Moderna share in Q3 2026, an estimated $108.
  • Moderna made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1121 holding.
  • Compass Financial Management first reported a position in Moderna in Q2 2026 and has held it in 2 quarters since.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.